RaySearch Laboratories AB (CHIX:RAYBS) Growth Rank: 10 (As of Sep. 02, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:RAYBS RaySearch Laboratories AB CHIX:RAYBS
94 GF Score
Price kr184.65
GF Value kr187.65
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Growth Rank?

RaySearch Laboratories AB CHIX:RAYBS 94 Growth Rank is 10 as of Sep. 02, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates CHIX:RAYBS with a GF Score™ of 94/100 and a GF Value™ of kr187.65 (Fairly Valued). The stock has 2 warning signs investors should review.

RaySearch Laboratories AB has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

RaySearch Laboratories AB Growth Rank Related Terms

CHIX:RAYBS vs VEEV, BTSG, TEM: Growth Rank Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RaySearch Laboratories AB Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Growth Rank distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Growth Rank falls into.


CHIX:RAYBS
94GF Score
RaySearch Laboratories AB CHIX:RAYBS
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
RaySearch Laboratories AB (CHIX:RAYBS) has a Growth Rank of 10 as of Sep. 02, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on RaySearch Laboratories AB and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, RaySearch Laboratories AB's Growth Rank has ranged from 2.00 to 10.00.
Is RaySearch Laboratories AB's Growth Rank too high?
RaySearch Laboratories AB's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, RaySearch Laboratories AB has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Growth Rank compare to VEEV and BTSG?
RaySearch Laboratories AB's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, RaySearch Laboratories AB's own Growth Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (CHIX:RAYBS) is currently considered Fairly Valued. The stock's GF Value™ is kr187.65, compared to a current price of kr184.65 — trading 1.6% below its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. RaySearch Laboratories AB's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For RaySearch Laboratories AB (CHIX:RAYBS), the current Growth Rank is 10 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (CHIX:RAYBS) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued. The current stock price of kr184.65 is trading 1.6% below its estimated GF Value™ of kr187.65. GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.

Key valuation signals for CHIX:RAYBS:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: kr187.65 vs. price of kr184.65 (1.6% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the CHIX:RAYBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
94GF Score

Get the complete analysis for CHIX:RAYBS

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr184.65
Price
kr187.65
GF Value